Literature DB >> 24459840

Beta-glucuronidase and Beta-glucosidase activity in stool specimens of children with inflammatory bowel disease.

Marta Mroczyńska1, Miroslawa Galecka2, Patrycja Szachta2, Dorota Kamoda1, Zdzislawa Libudzisz1, Dorota Roszak3.   

Abstract

The aim of the study was to analyze the differences in the activity of beta-glucuronidase and beta-glucosidase in stool specimens of children with Inflammatory Bowel Diseases (IBD) and healthy subjects. The disease activity was determined according to the PCDAI scale (Crohn disease) and Truelove-Witts scale (Ulcerative colitis). Enzyme activity was determined by spectrophotometry. There was a correlation between the level of beta - glucosidase activity in stool and patient's age in the group of healthy controls, but not in the IBD group. beta-glucosidase activity in IBD and healthy subjects stool specimens did not differ significantly. The activity of beta-glucuronidase in children with IBD was two times lower than in the healthy group and was correlated with age in children with IBD, but not in the group of healthy ones.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24459840

Source DB:  PubMed          Journal:  Pol J Microbiol        ISSN: 1733-1331


  8 in total

1.  Probiotic characterization of Lactobacillus brevis KU15153 showing antimicrobial and antioxidant effect isolated from kimchi.

Authors:  Hye Ji Jang; Na-Kyoung Lee; Hyun-Dong Paik
Journal:  Food Sci Biotechnol       Date:  2019-03-04       Impact factor: 2.391

2.  Effects of Resistant Dextrin from Potato Starch on the Growth Dynamics of Selected Co-Cultured Strains of Gastrointestinal Bacteria and the Activity of Fecal Enzymes.

Authors:  Michał Włodarczyk; Katarzyna Śliżewska; Renata Barczyńska; Janusz Kapuśniak
Journal:  Nutrients       Date:  2022-05-22       Impact factor: 6.706

3.  Plasma Beta-Glucuronidase Activity: A Novel Tool to Distinguish Type 1 from Type 2 Amiodarone-Induced Thyrotoxicosis?

Authors:  Georgios K Markantes; Marina A Michalaki; George A Vagenakis; Fotini N Lamari; Efthymia Pitsi; Maria Eliopoulou; Nicholas G Beratis; Kostas B Markou
Journal:  Eur Thyroid J       Date:  2019-07-15

Review 4.  Update on clinical and research application of fecal biomarkers for gastrointestinal diseases.

Authors:  Imran Siddiqui; Hafsa Majid; Shahab Abid
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-02-06

5.  β-Glucuronidases of opportunistic bacteria are the major contributors to xenobiotic-induced toxicity in the gut.

Authors:  Punsaldulam Dashnyam; Ramesh Mudududdla; Tung-Ju Hsieh; Ting-Chien Lin; Hsien-Ya Lin; Peng-Yuan Chen; Chia-Yi Hsu; Chun-Hung Lin
Journal:  Sci Rep       Date:  2018-11-06       Impact factor: 4.379

6.  Role of L. plantarum KX519413 as Probiotic and Acacia Gum as Prebiotic in Gastrointestinal Tract Strengthening.

Authors:  Honey Chandran C; Sreelekshmi Kumar; Rakhie Narayanan; Keerthi T R
Journal:  Microorganisms       Date:  2019-12-06

7.  Fecal β-glucuronidase activity differs between hematopoietic cell and kidney transplantation and a possible mechanism for disparate dose requirements.

Authors:  Mohammad Haneef Khan; Guillaume C Onyeaghala; Armin Rashidi; Shernan G Holtan; Alexander Khoruts; Ajay Israni; Pamala A Jacobson; Christopher Staley
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 8.  Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases.

Authors:  Alicja Derkacz; Pawel Olczyk; Katarzyna Komosinska-Vassev
Journal:  Dis Markers       Date:  2018-06-11       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.